← Open Payments lookup

ABBI LAMPARELLI: Open Payments

NPI 1255103172 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$474 in 21 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $118 · 2025 $474

Food & beverage: $474
CompanyPaymentsAmount
ABBVIE INC.7$147
Salix Pharmaceuticals, a division of Bausch Health US, LLC4$90
Madrigal Pharmaceuticals3$90
Optinose US, Inc.2$51
Ipsen Biopharmaceuticals, Inc1$22
Novo Nordisk Inc1$21
Takeda Pharmaceuticals U.S.A., Inc.1$21
Phadia US Inc.1$19
QOL Medical, LLC1$14

Products named: XIFAXAN, REZDIFFRA, CREON, LINZESS, Xhance, IQIRVO, Wegovy, ENTYVIO.

Industry payments across MD — which companies pay providers there.